Literature DB >> 20930569

A new view on development of a Staphylococcus aureus vaccine: insights from mice and men.

Brad Spellberg1, Robert Daum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20930569      PMCID： PMC3049966          DOI： 10.4161/hv.6.10.12469

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN： 1554-8600


× No keyword cloud information.
  19 in total

1.  Risk factors for hospital-acquired Staphylococcus aureus bacteremia.

Authors:  A G Jensen; C H Wachmann; K B Poulsen; F Espersen; J Scheibel; P Skinhøj; N Frimodt-Møller
Journal:  Arch Intern Med       Date:  1999-07-12

2.  Methicillin-resistant Staphylococcus aureus disease in three communities.

Authors:  Scott K Fridkin; Jeffrey C Hageman; Melissa Morrison; Laurie Thomson Sanza; Kathryn Como-Sabetti; John A Jernigan; Kathleen Harriman; Lee H Harrison; Ruth Lynfield; Monica M Farley
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

3.  Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

Authors:  Henry Shinefield; Steven Black; Ali Fattom; Gary Horwith; Scott Rasgon; Juan Ordonez; Hock Yeoh; David Law; John B Robbins; Rachel Schneerson; Larry Muenz; Steve Fuller; Joanie Johnson; Bruce Fireman; Harry Alcorn; Robert Naso
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

4.  Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections.

Authors:  Kevin B Laupland; Deirdre L Church; Melissa Mucenski; Lloyd R Sutherland; H Dele Davies
Journal:  J Infect Dis       Date:  2003-04-15       Impact factor: 5.226

5.  Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses.

Authors:  Harumichi Ishigame; Shigeru Kakuta; Takeshi Nagai; Motohiko Kadoki; Aya Nambu; Yutaka Komiyama; Noriyuki Fujikado; Yuko Tanahashi; Aoi Akitsu; Hayato Kotaki; Katsuko Sudo; Susumu Nakae; Chihiro Sasakawa; Yoichiro Iwakura
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

6.  Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines.

Authors:  John B Robbins; Rachel Schneerson; Gary Horwith; Robert Naso; Ali Fattom
Journal:  Am Heart J       Date:  2004-04       Impact factor: 4.749

7.  Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus.

Authors:  Lin Lin; Ashraf S Ibrahim; Beverlie Baquir; Valentina Avanesian; Yue Fu; Brad Spellberg
Journal:  FEMS Immunol Med Microbiol       Date:  2009-01-13

Review 8.  Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.

Authors:  Ali I Fattom; Gary Horwith; Steve Fuller; Myra Propst; Robert Naso
Journal:  Vaccine       Date:  2004-02-17       Impact factor: 3.641

9.  Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice.

Authors:  Lin Lin; Ashraf S Ibrahim; Xin Xu; Joshua M Farber; Valentina Avanesian; Beverlie Baquir; Yue Fu; Samuel W French; John E Edwards; Brad Spellberg
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

10.  Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.

Authors:  Antonella Torosantucci; Paola Chiani; Carla Bromuro; Flavia De Bernardis; Angelina S Palma; Yan Liu; Giuseppina Mignogna; Bruno Maras; Marisa Colone; Annarita Stringaro; Silvia Zamboni; Ten Feizi; Antonio Cassone
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240
View more
  9 in total

1.  A MRSA-terious enemy among us: boosting MRSA vaccines.

Authors:  Scott D Kobayashi; Frank R DeLeo
Journal:  Nat Med       Date:  2011-02       Impact factor: 53.440

2.  Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.

Authors:  Brian L Cheng; Travis B Nielsen; Paul Pantapalangkoor; Fan Zhao; Jean C Lee; Christopher P Montgomery; Brian Luna; Brad Spellberg; Robert S Daum
Journal:  Hum Vaccin Immunother       Date:  2017-04-19       Impact factor: 3.452

3.  Host response signature to Staphylococcus aureus alpha-hemolysin implicates pulmonary Th17 response.

Authors:  Karen M Frank; Tong Zhou; Liliana Moreno-Vinasco; Brian Hollett; Joe G N Garcia; Juliane Bubeck Wardenburg
Journal:  Infect Immun       Date:  2012-06-25       Impact factor: 3.441

4.  Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing.

Authors:  Pamela S Hair; Caitlin K Foley; Neel K Krishna; Julius O Nyalwidhe; Joan A Geoghegan; Timothy J Foster; Kenji M Cunnion
Journal:  Results Immunol       Date:  2013-11-09

5.  Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model.

Authors:  Amita Joshi; Greg Pancari; Leslie Cope; Edward P Bowman; Daniel Cua; Richard A Proctor; Tessie McNeely
Journal:  Hum Vaccin Immunother       Date:  2012-02-13       Impact factor: 3.452

6.  An extracellular Staphylococcus epidermidis polysaccharide: relation to Polysaccharide Intercellular Adhesin and its implication in phagocytosis.

Authors:  Anastasia I Spiliopoulou; Maria I Krevvata; Fevronia Kolonitsiou; Llinos G Harris; Thomas S Wilkinson; Angharad P Davies; Georgios O Dimitracopoulos; Nikos K Karamanos; Dietrich Mack; Evangelos D Anastassiou
Journal:  BMC Microbiol       Date:  2012-05-17       Impact factor: 3.605

7.  Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.

Authors:  Jack Levy; Laurent Licini; Edwige Haelterman; Philippe Moris; Pascal Lestrate; Silvia Damaso; Pascale Van Belle; Dominique Boutriau
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition.

Authors:  Brian M Luna; Travis B Nielsen; Brian Cheng; Paul Pantapalangkoor; Jun Yan; Susan Boyle-Vavra; Kevin W Bruhn; Christopher Montgomery; Brad Spellberg; Robert Daum
Journal:  PLoS One       Date:  2019-06-10       Impact factor: 3.240

Review 9.  The expanding horizon of prosthetic joint infections.

Authors:  Mayar Al Mohajer; Rabih O Darouiche
Journal:  J Appl Biomater Funct Mater       Date:  2014-06-12       Impact factor: 2.604
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.